A new study suggests the MAGIC Composite Response metric, which combines clinical and biomarker data, improves prediction of ...

Research reveals innovative methods for detecting minimal residual disease in ovarian cancer, enhancing prognosis and paving ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Early results from the TUSCANY trial highlight promising remission rates and safety for a new triplet therapy in treating ...

During a live event, Steven I. Robinson, MBBS, discussed desmoid tumor statistics and management for symptomatic progression.

Emerging treatments for low-grade serous ovarian cancer and platinum-resistant disease offer new hope, with promising data ...